Additionally, the 36-month beta value for IMTX is 0.75. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 4 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for IMTX is 72.03M and currently, short sellers hold a 15.00% ratio of that float. The average trading volume of IMTX on October 03, 2024 was 319.08K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IMTX) stock’s latest price update
The stock of Immatics N.V (NASDAQ: IMTX) has decreased by -6.16 when compared to last closing price of 11.21.Despite this, the company has seen a loss of -10.85% in its stock price over the last five trading days. globenewswire.com reported 2024-09-16 that Houston, Texas and Tuebingen, Germany, September 16, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today presented the proof-of-concept clinical data for the first candidate of its next-generation, half-life extended TCR Bispecifics platform, TCER® IMA401 (MAGEA4/8), during an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2024.
IMTX’s Market Performance
IMTX’s stock has fallen by -10.85% in the past week, with a monthly drop of -4.80% and a quarterly drop of -11.00%. The volatility ratio for the week is 3.57% while the volatility levels for the last 30 days are 4.24% for Immatics N.V The simple moving average for the past 20 days is -11.60% for IMTX’s stock, with a -8.56% simple moving average for the past 200 days.
Analysts’ Opinion of IMTX
Mizuho, on the other hand, stated in their research note that they expect to see IMTX reach a price target of $12. The rating they have provided for IMTX stocks is “Buy” according to the report published on March 31st, 2023.
Bryan Garnier gave a rating of “Buy” to IMTX, setting the target price at $16 in the report published on March 24th of the previous year.
IMTX Trading at -10.19% from the 50-Day Moving Average
After a stumble in the market that brought IMTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.60% of loss for the given period.
Volatility was left at 4.24%, however, over the last 30 days, the volatility rate increased by 3.57%, as shares sank -6.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.58% lower at present.
During the last 5 trading sessions, IMTX fell by -10.85%, which changed the moving average for the period of 200-days by +7.35% in comparison to the 20-day moving average, which settled at $11.86. In addition, Immatics N.V saw -0.09% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for IMTX
Current profitability levels for the company are sitting at:
- -1.42 for the present operating margin
- -0.35 for the gross margin
The net margin for Immatics N.V stands at -1.04. The total capital return value is set at -0.21. Equity return is now at value -24.37, with -14.23 for asset returns.
Based on Immatics N.V (IMTX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -0.48. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -119.28.
Currently, EBITDA for the company is -80.65 million with net debt to EBITDA at 1.48. When we switch over and look at the enterprise to sales, we see a ratio of 12.09. The receivables turnover for the company is 19.67for trailing twelve months and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.74.
Conclusion
In conclusion, Immatics N.V (IMTX) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
